At week 16, more patients without food allergies who took placebo reported treatment-emergent adverse events (TEAE) than patients who took dupilumab. Additionally, more patients with asthma ...

There have been new developments in treatments for chronic spontaneous urticaria, with dupilumab, remibrutinib, and ...

A drug billed by Sanofi as a successor to its blockbuster inflammation and immunology blockbuster Dupixent is being prepared for phase 3 trials in asthma – even though it missed the mark in a midstage ...

18 months after saying "no" to regular NHS funding for Sanofi and Regeneron's Dupixent (dupilumab) for severe asthma in initial guidance, NICE has now backed the drug. The final appraisal ...

Sanofi SNY announced preliminary data from the phase II TIDE-Asthma study, which evaluated its anti-OX40L mAb, amlitelimab, ...

It’s not just in your stuffy head. Seasonal allergies are getting worse as pollen season gets longer and more intense.

Prolonged eosinophilia in the tissues of asthma and CRSwNP patients has been associated with ... Additionally, biological treatments are available for severe cases, such as dupilumab (monoclonal ...

Ann Allergy Asthma Immunol. 2019;122(5):449-455 ... Topical Calcineurin Inhibitors (TCIs) National Eczema Society. Dupilumab. National Eczema Society. Methotrexate.

The Global Allergy and Asthma Excellence Network has published a consensus report on anaphylaxis — including an updated definition, overview and clinical support tool — in The Journal of ...

Responses to dupilumab (Dupixent) treatment were consistent across racial and ethnic groups in children with atopic dermatitis. “The results of this study suggest that race and ethnicity do not ...

If you’re bothered by allergies every spring, you may pop a Benadryl or Claritin most mornings to make the days tolerable.